Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
How Our Practice Answers These Questions We think you should hold us to the same standard, so here are our answers: Live provider, every patient
Nature 590, 140145
Pfister D, Schonberger H, Rank CM, et al
Converting Your Vial Into an Accurate, Measurable Dose A reference chart covering common CJC-1295 concentrations, U-100 syringe units, mL conversions, and reconstitution examples to help you understand your prescription
Research-context information only
Even if these approaches are successful in many cases, there is still a subset (3%5% of patients) that progress to therapeutically refractive disease, constituting the so-called TC-related deaths due to the lack of effective treatment. In this view, some efforts are ongoing to identify personalized therapy for refractory patients and drug repositioning represents one of the potential alternatives (Xu et al., 2019)
